US Stock MarketDetailed Quotes

ANAB AnaptysBio

Watchlist
  • 21.170
  • +0.860+4.23%
Trading Nov 21 15:47 ET
644.18MMarket Cap-3499P/E (TTM)

AnaptysBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AnaptysBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.950M--
--2024/Q4-- / 10.088M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.950M--
--2024/Q4-- / 10.088M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--

Unlock Free Earnings Estimates

AnaptysBio Earnings Reports

  • AnaptysBio | 10-Q: Q3 2024 Earnings Report

    Nov 6 05:22

  • AnaptysBio | 10-Q: Q2 2024 Earnings Report

    Aug 6 04:27

  • AnaptysBio | 10-Q: Q1 2024 Earnings Report

    May 10 04:30

  • AnaptysBio | 10-K: FY2023 Annual Report

    Mar 12 04:40

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Strong Buy

    • Buy

      84.62%

    • Hold

      15.39%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data